TheCMF-regimen. Modulation of cyclophosphamide uptake and clearance by methotrexate and fluorouracil

This publication has 7 references indexed in Scilit:

• A Randomized Clinical Trial Evaluating Sequential Methotrexate and Fluorouracil in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor-Negative Tumors
  New England Journal of Medicine, 1989
• Pharmacokinėtics of intravenous and oral cyclophosphamide in the presence of methotrexate and fluorouracil
  International Journal of Clinical Pharmacy, 1988
• The influence of ethanol on cyclophosphamide pharmacokinetics and metabolism in tumor-bearing rats
  Pharmacology & Therapeutics, 1987
• Monitoring the behaviour of 4-ketocyclophosphamideversus cyclophosphamide during capillary gas chromatography by mass spectrometry
  Journal of Mass Spectrometry, 1987
• Adjuvant Therapy in Primary Breast Cancer
  Surgical Clinics of North America, 1985
• Bioavailability of cyclophosphamide from oral formulations
  European Journal of Clinical Pharmacology, 1984
• Determination of the underivatized antineoplastic drugs cyclophosphamide and 5-fluorouracil and some their metabolites by capillary gas chromatography combined with electron-capture and nitrogen phosphorus selective detection
  Journal of Chromatography A, 1983